CClinicalTrials.gg
CompletedNCT02924441Updated Oct 12, 2022

Women's Mammography Study to Improve Comfort During Mammography

An interventional study of Lidocaine and Calming Music in Pain, sponsored by The University of Texas Health Science Center at San Antonio. Completed at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-10-12.

Sponsored by The University of Texas Health Science Center at San Antonio · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
251
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

To determine in a randomized trial whether it is possible to decrease the discomfort and anxiety of mammography by using the local analgesic lidocaine, or by using calming music in patients receiving a mammogram.

Read the detailed description

The study is designed to evaluate two methods of reducing pain and anxiety caused by mammography, one of the barriers to the procedure.

02

Conditions studied

  • Pain

Keywords

  • Mammogram
  • Pain Management
  • Lidocaine
03

In context

Lead sponsor

The University of Texas Health Science Center at San Antonio is the lead sponsor of 435 studies on the registry; 88 are open to participants now.

Of its 62 completed or terminated interventional studies of FDA-regulated products, 31 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Must either be getting her first mammogram or based on prior experience be expecting level 4 or 5 pain.
  • Must have two breasts

Exclusion criteria

Exclusion Criteria:

  • May not have taken ibuprofen or other pain medication within the Space last 12 hours (ASA 81 mg dose is allowed).
  • Must not have a contraindication for using lidocaine: e.g no history of allergic reactions to lidocaine.
  • Must not have had history of breast cancer, breast surgery, radiation to the chest wall.
  • Must not have broken or irritated skin (as determined by the study nurses).
  • May not be lactating or breast feeding
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
251 participants (actual)

Study arms

  • Experimental
    Right Breast Lidocaine and calming music

    Group 1 - right breast lidocaine \& calming music

    Other: Lidocaine · Other: Calming Music

  • Experimental
    Right Breast Lidocaine and no music

    Group 2 - right breast lidocaine \& no calming music

    Other: Lidocaine · Other: No Music

  • Experimental
    Left Breast Lidocaine and calming music

    Group 3 - left breast lidocaine \& calming music

    Other: Lidocaine · Other: Calming Music

  • Experimental
    Left Breast Lidocaine and no music

    Group 4 - left breast lidocaine \& no calming music

    Other: Lidocaine · Other: No Music

Interventions

  • OtherLidocaine

    Applied to breast skin

    Also known as: Topicaine

  • OtherCalming Music

    Played during mammography

  • OtherNo Music

    No music played during mammography

06

What researchers measure

Primary outcomes

  1. Questionnaire to determine the change (or difference) in pain level before and after mammogram

    The questionnaires will be typically be completed about 60 minutes apart. The first questionnaire will be completed before any intervention. The second questionnaire will be administered at the earliest at about 35 minutes later (after application of the gels and performance of mammography). The longest interval between administration of the questionnaires would be 75 minutes (after which time the gel must be removed, per protocol).

    Time frame: The questionnaires are completed before and after mammography, on the same day (questionnaire will be completed before leaving the mammography clinic the day of mammography).

07

Study locations

1 site
  • UT Health Cancer Center
    San Antonio, Texas 78260, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 12, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02924441
Lead sponsor
The University of Texas Health Science Center at San Antonio
Responsible party
Sponsor
First posted
Oct 5, 2016
Start date
Oct 1, 2016
Primary completion
Jan 15, 2020
Completion
Aug 3, 2022
Last update
Oct 12, 2022

Study contacts

Kenneth Kist, MD
principal investigator · CTRC @ UTHSCSA
Virginia Kaklamani, MD
study chair · CTRC @ UTHSCSA
Pamela Otto, MD
study chair · CTRC @ UTHSCSA

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion